NCT06710314View on ClinicalTrials.gov

A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer

Enrolling by invitationOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

July 1, 2026

Conditions
Metabolomics
Interventions
DIAGNOSTIC_TEST

Colorectal cancer patients with hypertension

Colorectal cancer patients with hypertension

DIAGNOSTIC_TEST

Colorectal cancer patients with diabetes

Colorectal cancer patients with diabetes

DIAGNOSTIC_TEST

Colorectal cancer patients with fatty liver

Colorectal cancer patients with fatty liver

Trial Locations (1)

420006

Chongqing medical university, Chongqing

All Listed Sponsors
lead

Dong Peng

OTHER